LAVETA JARRETT: Open Payments
NPI 1588890404 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 46 payments from 14 companies in 2025. Trend: 2023 $1,219 · 2024 $1,266 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 12 | $203 |
| Otsuka America Pharmaceutical, Inc. | 7 | $132 |
| Janssen Scientific Affairs, LLC | 1 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $104 |
| ABBVIE INC. | 5 | $93 |
| Vanda Pharmaceuticals Inc. | 4 | $77 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Neurocrine BioSciences, Inc. | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 2 | $31 |
| Almatica Pharma LLC | 1 | $23 |
Products named: Azstarys, REXULTI, SPRAVATO, CAPLYTA, VRAYLAR, FANAPT, COBENFY, INGREZZA.
Industry payments across KS — which companies pay providers there.
